Cargando…
C-Reactive Protein and Cancer: Interpreting the Differential Bioactivities of Its Pentameric and Monomeric, Modified Isoforms
C-reactive protein (CRP) was first recognized in the 1940s as a protein that appeared in blood during acute episodes of infectious disease. Its presence and pharmacodynamics were found in essentially all diseases that involved tissue damage and inflammation. Identified as a major component of the in...
Autores principales: | Potempa, Lawrence A., Rajab, Ibraheem M., Olson, Margaret E., Hart, Peter C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450391/ https://www.ncbi.nlm.nih.gov/pubmed/34552600 http://dx.doi.org/10.3389/fimmu.2021.744129 |
Ejemplares similares
-
A biofunctional review of C-reactive protein (CRP) as a mediator of inflammatory and immune responses: differentiating pentameric and modified CRP isoform effects
por: Olson, Margaret E., et al.
Publicado: (2023) -
How C-Reactive Protein Structural Isoforms With Distinctive Bioactivities Affect Disease Progression
por: Rajab, Ibraheem M., et al.
Publicado: (2020) -
C-Reactive Protein and Cancer—Diagnostic and Therapeutic Insights
por: Hart, Peter C., et al.
Publicado: (2020) -
Monomeric C‐reactive protein induces the cellular pathology of Alzheimer's disease
por: Gan, Qini, et al.
Publicado: (2022) -
Opposing effects of monomeric and pentameric C-reactive protein on endothelial progenitor cells
por: Ahrens, I., et al.
Publicado: (2011)